Washington, Feb. 6 -- Congresswoman Diana DeGette issued the following press release:
Today, Congressional Diabetes Caucus Co-Chairs Diana DeGette (CO-01) and Gus Bilirakis (FL-12) released the following statement after the Federal Trade Commission (FTC) announced a settlement with one of the nation's largest pharmacy benefit managers (PBM), Express Scripts, Inc., and its affiliated entities.
"For years, the Diabetes Caucus has been focused on lowering the cost of insulin for the millions of Americans who rely on it to manage their blood sugar levels and on holding PBMs accountable for their role in insulin's high cost. This settlement is an important victory for people with diabetes over companies that have steered patients towards high...